In addition, patients carrying two C alleles for GSTO1 rs4925 had a lower risk of bladder cancer recurrence (CC/(AC+AA): HR = 0.51, 95% CI = 0.27–0.95). This evidence concerns the gene GSTO1 and urinary bladder carcinoma.